Skip to main content
. 2017 Sep 13;13:2389–2396. doi: 10.2147/NDT.S135624

Table 2.

Prevalence of major depression based on risk factors in breast cancer patients (N=300)

Variables Group Major depression/total number Prevalence (%) 95% CI (%) p-value
Total patients 25/300 8.33 5.21–11.46
Basic characteristics
 Age 18–40 years 8/63 12.7 4.48–20.9 0.343
41–54 years 13/171 7.60 3.63–11.6
≥55 years 4/66 6.06 0.31–11.8
 Marriage No 6/74 8.11 1.89–14.3 0.928
Yes 19/225 8.44 4.81–12.1
 Cigarette smoking No 22/270 8.15 4.88–11.4 0.793
Yes 3/29 10.3 0.0–21.4
 Alcohol drinking No 18/197 9.14 5.11–13.2 0.515
Yes 7/101 6.93 1.98–11.9
 Regular exercise Yes 11/172 6.40 2.74–10.1 0.153
No 14/127 11.0 5.58–16.5
Psychosocial factors
 Insomnia Yes 16/119 13.5 7.32–19.6 0.010
No 9/180 5.00 1.81–8.18
 Taking sleeping pills Yes 8/47 17.0 6.28–27.8 0.019
No 17/252 6.75 3.65–9.84
 Psychiatric family history Yes 6/27 22.2 6.54–37.9 0.006
No 19/254 7.48 4.25–10.7
 Chronic pain within one year Yes 14/84 16.7 8.70–24.6 0.001
No 11/215 5.12 2.17–8.06
Cancer related factors
 Menopause Yes 10/180 5.60 2.21–8.90 0.031
No 15/119 12.6 6.64–18.6
 Duration of breast cancer ≤1 year 18/150 12.0 6.80–17.2 0.012
>1 year 6/148 4.05 0.88–7.23
 Stage of cancer I–III 20/249 3.4 1.15–5.65 0.540
IV 1/9 4.8 −9.17–18.8
Treatments
 Operation Yes 21/247 8.50 5.02–12.0 0.819
No 4/53 7.55 0.44–14.7
 Radiation therapy Yes 20/176 11.36 6.67–16.1 0.024
No 5/124 4.03 0.57–7.49
 Hormone therapy Yes 13/210 6.19 2.93–9.45 0.040
No 12/90 13.33 6.31–20.4
 Chemotherapy Yes 20/215 9.30 5.42–13.2 0.334
No 5/85 5.88 0.88–10.9
 Target-drug therapy Yes 8/68 11.7 4.11–19.4 0.244
No 17/232 7.33 3.97–10.7